Beh?et’s disease (BD) is a multi-systemic vasculitis characterized by a triad made up of oral aphthosis, genital aphthosis and uveitis which may or may not be associated with visceral involvement. Other times described in the ancient silk road, BD is increasingly found in countries south of the Sahara with the mixing of populations. Our objective was to describe the epidemiology and clinical characteristics of BD in an African country. Methodology: This was a five-year retrospective study in the internal medicine department of Donka National Hospital. We used international criteria finding BD. Urinary dipstick was use for finding kidney disease. Result: During the period, five cases of Beh?et’s disease were collected. The average age was 35 years old. The male sex was more represented with 3 out of 5 cases. The most common clinical manifestation was oral aphthosis in all patients (100%), followed by genital aphthosis in 4 cases (80%). The other clinical manifestations observed were uveitis in 3 cases (60%), joint manifestations such as arthralgia in 3 cases (60%) and neurological manifestations such as chronic headache in one case (20%). HLA-B51 was found in two cases. The pattergic test done in two patients came back positive (100%). The patients received colchicine and oral corticosteroid therapy. Two patients were lost to sight. We deplored a death probably in a neuro-Beh?et table before the rebellious headaches. Conclusion: Beh?et’s disease is a multi-systemic vasculitis that must be evoked and managed quickly in a tropical environment, especially since the prognosis, vital and functional prognosis can be engaged.
References
[1]
Filali-Ansary, N. et al. (2002) Maladie de Behçet: Maroc Médical, tome 24 No. 3.
[2]
Kaklamani, V.G., Vaiopoulos, G. and Kaklamanis, P.G. (1998) Behçet’s Disease. Seminars in Arthritis and Rheumatism, 27, 197-217. https://doi.org/10.1016/S0049-0172(98)80001-2
[3]
Berthé, A., Diack, M., Gaye, A., Gueye, A.D., Marone, Z., Ndiaye, Y., et al. (2022) Parcours diagnostic de la maladie de Behçet en milieu tropical: Expérience dans un service de médecine interne (à propos de 6 cas). Revue Africaine de Médecine Interne, 9, 69-76.
[4]
Labou, A. (1996) Mise au point sur la maladie de Behçet à Dakar. Donka National Hospital instead of Teaching, Dakar.
[5]
Alli, N., Gur, G., Yalcin, B. and Hayran, M. (2009) Patient Characteristics in Behçet Disease: 41A Retrospective Analysis of 213 Turkish Patients during 2001-4. American Journal of Clinical Dermatology, 10, 411-418. https://doi.org/10.2165/11310880-000000000-00000
[6]
Razzak, A., Kassimi, A., Mchachi, A., Benhmidoune, L., Chakib, A., et al. (2019) (Eil et Maladie de Behçet: Profil épidémiologique, clinique, thérapeutique et évolutif. The Pan African Medical Journal, 33, Article 116. https://doi.org/10.11604/pamj.2019.33.116.17111
[7]
Behçet, H. (1937) Uber rezidivierende, aphtose, durchein virus verusachte Gaschwure am mund, am auge und an den genitalie. Dermat Wochsch, 105, 1152-1157.
[8]
Sakane, T., Takeno, M., Suzuki, N. and Inaba, G. (1999) Behcet’s Disease. The New England Journal of Medicine, 341, 1284-1291. https://doi.org/10.1056/NEJM199910213411707
[9]
Evereklioglu, C. (2005) Current Concepts in the Etiology and Treatment of Behcet’s Disease. Survey of Ophthalmology, 50, 297-350. https://doi.org/10.1016/j.survophthal.2005.04.009
[10]
Dia, D., Dieng, M.T., Sy Ndiaye, T., Fall, S., Ndongo, S., Diallo, M., et al. (2003) Behçet’s Disease in Dakar (Sénégal): Epidemiological and Clinical Features. Dakar Medical, 48, 64-67.
[11]
Niang, P., Tine, S.D., Ba, A., et al. (2009) Manifestations buccales de la maladie de Behçet. A propos de 12 cas au Sénégal. Médecine buccale chirurgie buccale, 15, 183-188. https://doi.org/10.1051/mbcb/2009030
[12]
Hamzaoui, A., Klii, R., Harzallah, O., Attig, C. and Mahjoub, S. (2012) La maladie de Behçet chez la femme. La Revue de Médecine Interne, 10, 552-555. https://doi.org/10.1016/j.revmed.2012.06.007
[13]
Salvaranic, C., Pipitone, N., Grazia Catanoso, M., Cimino, L., Tumiati, B., et al. (2007) Epidemiology and Clinical Course of Behcet’s Disease in the Reggio Emilia Area of Northern Italy: A Seventeen-Year Population-Based Study. Arthritis & Rheumatism (Arthritis Care & Research), 57, 171-178. https://doi.org/10.1002/art.22500
[14]
Otmani, F. (2009) Behcet’s Disease: New Therapeutics. La Revue de Médecine Interne, 30, S243-S252. https://doi.org/10.1016/j.revmed.2009.09.023
[15]
Lamini, N., Soundhat, N.E., Nganga Ngabou, C.G.F., Mimiesse, J.F., et al. (2017) Maladie de behçet avec atteinte systémique. Bulletin Médical d’Owendo, 15, 63-66.
[16]
Savey, L., Resche-Rigon, M. and Saadoun, D. (2014) Ethnicity and Association with Disease Manifestations and Mortality in Behçet’s Disease. Orphanet Journal of Rare Diseases, 9, Article No. 42. https://doi.org/10.1186/1750-1172-9-42